Josephine H Cox - JoVE Visualize

Showing results (11-20 of 51) with videos related to

Pageof 6

Sort By:

AIDS Reviews|June 1, 2004

Lost in translation: implications of HIV-1 codon usage for immune escape and drug resistanceGustavo H Kijak, Jeffrey R Currier, Sodsai Tovanabutra, et al.

Journal of Immunological Methods|January 17, 2002

A panel of MHC class I restricted viral peptides for use as a quality control for vaccine trial ELISPOT assaysJeffrey R Currier, Ellen G Kuta, Ellen Turk, et al.

Vaccine|March 14, 2017

Cryopreservation-related loss of antigen-specific IFNγ producing CD4+ T-cells can skew immunogenicity data in vaccine trials: Lessons from a malaria vaccine trial substudyTom Ford, Claire Wenden, Alison Mbekeani, et al.

AIDS Research and Human Retroviruses|June 14, 2003

Longitudinal study of humoral immune responses in HIV type 1 subtype CRF01_AE (E)-infected Thai patients with different rates of disease progressionThippawan Chuenchitra, Chantapong Wasi, Suda Louisirirojchanakul, et al.

Clinical and Vaccine Immunology : CVI|December 14, 2007

Peptide impurities in commercial synthetic peptides and their implications for vaccine trial assessmentJeffrey R Currier, Lynee M Galley, Holger Wenschuh, et al.

Journal of Immunology (Baltimore, Md. : 1950)|November 11, 2018

Multiplexed FluoroSpot for the Analysis of Dengue Virus- and Zika Virus-Specific and Cross-Reactive Memory B CellsAwadalkareem Adam, Marcia Woda, Sonia Kounlavouth, et al.

AIDS Research and Human Retroviruses|July 13, 2006

Circulating and unique recombinant forms of HIV type 1 containing subsubtype A2Unchalee Visawapoka, Sodsai Tovanabutra, Jeffrey R Currier, et al.

AIDS (London, England)|October 3, 2003

Detection of high frequencies of HIV-1 cross-subtype reactive CD8 T lymphocytes in the peripheral blood of HIV-1-infected KenyansJeffrey R Currier, William E Dowling, K Monique Wasunna, et al.

Vaccine|August 6, 2009

Design and evaluation of multi-gene, multi-clade HIV-1 MVA vaccinesPatricia L Earl, Catherine Cotter, Bernard Moss, et al.

AIDS (London, England)|April 19, 2016

Adenovirus-based HIV-1 vaccine candidates tested in efficacy trials elicit CD8+ T cells with limited breadth of HIV-1 inhibitionPeter J Hayes, Josephine H Cox, Adam R Coleman, et al.

Pageof 6

Showing results (11-20 of 51) with videos related to

Sort By:

Pageof 6

AIDS Reviews|June 1, 2004

Lost in translation: implications of HIV-1 codon usage for immune escape and drug resistanceGustavo H Kijak, Jeffrey R Currier, Sodsai Tovanabutra, et al.

Journal of Immunological Methods|January 17, 2002

A panel of MHC class I restricted viral peptides for use as a quality control for vaccine trial ELISPOT assaysJeffrey R Currier, Ellen G Kuta, Ellen Turk, et al.

Vaccine|March 14, 2017

Cryopreservation-related loss of antigen-specific IFNγ producing CD4+ T-cells can skew immunogenicity data in vaccine trials: Lessons from a malaria vaccine trial substudyTom Ford, Claire Wenden, Alison Mbekeani, et al.

AIDS Research and Human Retroviruses|June 14, 2003

Longitudinal study of humoral immune responses in HIV type 1 subtype CRF01_AE (E)-infected Thai patients with different rates of disease progressionThippawan Chuenchitra, Chantapong Wasi, Suda Louisirirojchanakul, et al.

Clinical and Vaccine Immunology : CVI|December 14, 2007

Peptide impurities in commercial synthetic peptides and their implications for vaccine trial assessmentJeffrey R Currier, Lynee M Galley, Holger Wenschuh, et al.

Journal of Immunology (Baltimore, Md. : 1950)|November 11, 2018

Multiplexed FluoroSpot for the Analysis of Dengue Virus- and Zika Virus-Specific and Cross-Reactive Memory B CellsAwadalkareem Adam, Marcia Woda, Sonia Kounlavouth, et al.

AIDS Research and Human Retroviruses|July 13, 2006

Circulating and unique recombinant forms of HIV type 1 containing subsubtype A2Unchalee Visawapoka, Sodsai Tovanabutra, Jeffrey R Currier, et al.

AIDS (London, England)|October 3, 2003

Detection of high frequencies of HIV-1 cross-subtype reactive CD8 T lymphocytes in the peripheral blood of HIV-1-infected KenyansJeffrey R Currier, William E Dowling, K Monique Wasunna, et al.

Vaccine|August 6, 2009

Design and evaluation of multi-gene, multi-clade HIV-1 MVA vaccinesPatricia L Earl, Catherine Cotter, Bernard Moss, et al.

AIDS (London, England)|April 19, 2016

Adenovirus-based HIV-1 vaccine candidates tested in efficacy trials elicit CD8+ T cells with limited breadth of HIV-1 inhibitionPeter J Hayes, Josephine H Cox, Adam R Coleman, et al.

Pageof 6